Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
For best results when printing this announcement, please click on link below: Alkermes to Present New Data on Alixorexton and LUMRYZ(®) (sodium oxybate) at Sleep Europe 2026, Underscoring Leadership in Sleep Medicine Research — Data From Vibrance-1 Phase 2 Study Lancet Neurology Publication Evaluating Alixorexton in Na
ANI Pharmaceuticals said SYNCHRONICITY trial results were presented as a late-breaking oral presentation at the American Academy of Ophthalmology 2026 Annual Meeting. The release says the trial reported six- and 24-month data.
The SYNCHRONICITY open-label, single-arm Phase 4 clinical trial results were presented as a late-breaking oral presentation at the American Academy of Ophthalmology 2026 Annual Meeting.